This study did not calculate the ICER or the incremental cost-utility ratio. This was because that there were no proper control groups for comparisons and outcomes related to quality of life were not measured. Instead, the ACERs of 5 herbal medicines were calculated with respect to height (cm) and height percentile for children with ISS. The ACER was calculated separately for boys and girls for each herbal medicine. Height standard deviation score and the cost before and after treatment are also presented.